Impact of Body Mass Index on the Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus: A Subgroup Analysis of 3‐month Interim Results From the STELLA ‐ LONG TERM Study

Journal of Diabetes Investigation - Australia
doi 10.1111/jdi.13021

Related search